IE
PSTX

Israel Englander’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History

Israel Englander’s Portfolio PSTX Stock Details PSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-205,000
Closed -$586K – 6585
2024
Q3 		$586K Buy
+205,000
New +$635K ﹤0.01% 4704

Other funds holding PSTX

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Israel Englander's PSTX Position: Q1 2025 in Review

Israel Englander sold out of Poseida Therapeutics, Inc. Common Stock (PSTX) in Q1 2025, closing a stake of 136,116 shares — an estimated $1.31M sold.

Israel Englander first reported a position in PSTX in Q3 2020 and held it in 18 quarters. The position peaked at $16.9M in Q1 2021. 1 fund tracked by Wall St. Rank holds PSTX as of Q1 2025.

  • Israel Englander reported no remaining Poseida Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Israel Englander sold 136,116 Poseida Therapeutics, Inc. Common Stock shares in Q1 2025, an estimated $1.31M.
  • Israel Englander first reported a position in Poseida Therapeutics, Inc. Common Stock in Q3 2020 and held it in 18 quarters.
  • Israel Englander's Poseida Therapeutics, Inc. Common Stock position peaked at $16.9M in Q1 2021.
  • 1 fund tracked by Wall St. Rank held Poseida Therapeutics, Inc. Common Stock as of Q1 2025.

Based on Millennium Management's 13F filing for Q1 2025, filed 15 May 2025.